Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. International most cancers statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 international locations. CA A Most cancers J Clin. 2021;71:209–49.
Shaukat A, Levin TR. Present and future colorectal most cancers screening methods. Nat Rev Gastroenterol Hepatol. 2022;19:521–31.
Patel SG, Karlitz JJ, Yen T, Lieu CH, Boland CR. The rising tide of early-onset colorectal most cancers: a complete overview of epidemiology, medical options, biology, threat components, prevention, and early detection. Lancet Gastroenterol Hepatol. 2022;7:262–74.
Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC. A potential examine of household historical past and the chance of colorectal most cancers. New Engl J Med. 1994;331:1669–74.
Syngal S, Model RE, Church JM, Giardiello FM, Hampel HL, Burt RW. ACG Scientific guideline: genetic testing and administration of hereditary gastrointestinal most cancers syndromes. Am J Gastroenterol. 2015;110:223.
Monahan KJ, Bradshaw N, Dolwani S, Desouza B, Dunlop MG, East JE, et al. Pointers for the administration of hereditary colorectal most cancers from the British Society of Gastroenterology (BSG)/Affiliation of Coloproctology of Nice Britain and Eire (ACPGBI)/United Kingdom Most cancers Genetics Group (UKCGG). Intestine. 2020;69:411.
Seppälä TT, Latchford A, Negoi I, Sampaio Soares A, Jimenez‐Rodriguez R, Sánchez‐Guillén L, et al. European tips from the EHTG and ESCP for Lynch syndrome: an up to date third version of the Mallorca tips based mostly on gene and gender. Br J Surg. 2021;108:484–98.
Legislation PJ, Timofeeva M, Fernandez-Rozadilla C, Broderick P, Studd J, Fernandez-Tajes J, et al. Affiliation analyses establish 31 new threat loci for colorectal most cancers susceptibility. Nat Commun. 2019;10:2154.
Fernandez-Rozadilla C, Timofeeva M, Chen Z, Legislation P, Thomas M, Schmit S, et al. Deciphering colorectal most cancers genetics by means of multi-omic evaluation of 100,204 circumstances and 154,587 controls of European and east Asian ancestries. Nat Genet. 2023;55:89–99.
Schmit SL, Edlund CK, Schumacher FR, Gong J, Harrison TA, Huyghe JR, et al. Novel widespread genetic susceptibility loci for colorectal most cancers. JNCI J Natl Most cancers Inst. 2018;111:146–57.
Huyghe JR, Bien SA, Harrison TA, Kang HM, Chen S, Schmit SL, et al. Discovery of widespread and uncommon genetic threat variants for colorectal most cancers. Nat Genet. 2019;51:76–87.
Briggs SEW, Legislation P, East JE, Wordsworth S, Dunlop M, Houlston R, et al. Integrating genome-wide polygenic threat scores and non-genetic threat to foretell colorectal most cancers analysis utilizing UK Biobank information: inhabitants based mostly cohort examine. BMJ. 2022;379:e071707.
Thomas M, Sakoda LC, Hoffmeister M, Rosenthal EA, Lee JK, Van Duijnhoven FJB, et al. Genome-wide modeling of polygenic threat rating in colorectal most cancers threat. Am J Hum Genet. 2020;107:432–44.
Archambault AN, Su Y-R, Jeon J, Thomas M, Lin Y, Conti DV, et al. Cumulative burden of colorectal most cancers–related genetic variants is extra strongly related to early-onset vs late-onset most cancers. Gastroenterology. 2020;158:1274–86.e12.
Carr PR, Weigl Ok, Jansen L, Walter V, Erben V, Chang-Claude J, et al. Wholesome way of life components related to decrease threat of colorectal most cancers no matter genetic threat. Gastroenterology. 2018;155:1805–15.e5.
Jeon J, Du M, Schoen RE, Hoffmeister M, Newcomb PA, Berndt SI, et al. Figuring out threat of colorectal most cancers and beginning age of screening based mostly on way of life, environmental, and genetic components. Gastroenterology. 2018;154:2152–64.e19.
Hassanin E, Spier I, Bobbili DR, Aldisi R, Klinkhammer H, David F, et al. Clinically related mixed impact of polygenic background, uncommon pathogenic germline variants, and household historical past on colorectal most cancers incidence. BMC Med Genomics. 2023;16:42.
Brenner H, Altenhofen L, Inventory C, Hoffmeister M. Pure historical past of colorectal adenomas: start cohort evaluation amongst 3.6 million individuals of screening colonoscopy. Most cancers Epidemiol Biomark Prev. 2013;22:1043–51.
Brenner H, Hoffmeister M, Arndt V, Haug U. Gender variations in colorectal most cancers: implications for age at initiation of screening. Br J Most cancers. 2007;96:828–31.
Kim SE, Paik HY, Yoon H, Lee JE, Kim N, Sung MK. Intercourse- and gender-specific disparities in colorectal most cancers threat. World J Gastroenterol. 2015;21:5167–75.
Wang L, Lo CH, He X, Hold D, Wang M, Wu Ok, et al. Threat issue profiles differ for cancers of various areas of the colorectum. Gastroenterology. 2020;159:241–56.e13.
Huyghe JR, Harrison TA, Bien SA, Hampel H, Figueiredo JC, Schmit SL, et al. Genetic architectures of proximal and distal colorectal most cancers are partly distinct. Intestine. 2021;70:1325–34.
Nishihara R, Wu Ok, Lochhead P, Morikawa T, Liao X, Qian ZR, et al. Lengthy-term colorectal-cancer incidence and mortality after decrease endoscopy. New Engl J Med. 2013;369:1095–105.
Kaminski MF, Regula J, Kraszewska E, Polkowski M, Wojciechowska U, Didkowska J, et al. High quality indicators for colonoscopy and the chance of interval most cancers. New Engl J Med. 2010;362:1795–803.
Kurki MI, Karjalainen J, Palta P, Sipilä TP, Kristiansson Ok, Donner KM, et al. FinnGen supplies genetic insights from a well-phenotyped remoted inhabitants. Nature. 2023;613:508–18.
Leinonen MK, Miettinen J, Heikkinen S, Pitkäniemi J, Malila N. High quality measures of the population-based Finnish Most cancers Registry point out sound information high quality for stable malignant tumours. Eur J Most cancers. 2017;77:31–9.
Teppo L, Pukkala E, Lehtonen M. Information high quality and high quality management of a population-based most cancers registry: expertise in Finland. Acta Oncologica. 1994;33:365–9.
Ge T, Chen C-Y, Ni Y, Feng Y-CA, Smoller JW. Polygenic prediction by way of Bayesian regression and steady shrinkage priors. Nat Commun. 2019;10:1776.
Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, et al. A world reference for human genetic variation. Nature. 2015;526:68–74.
Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. International burden of 369 illnesses and accidents in 204 international locations and territories, 1990–2019: a scientific evaluation for the International Burden of Illness Research 2019. Lancet. 2020;396:1204–22.
Bradley J, Kristi L, Brooke NW, Ying W, Kristina Z, Yipeng C, et al. A unified framework for estimating country-specific cumulative incidence for 18 illnesses stratified by polygenic threat. medRxiv [Preprint] 2023. https://doi.org/10.1101/2023.06.12.23291186.
Win AK, Dowty JG, Reece JC, Lee G, Templeton AS, Plazzer J-P, et al. Variation within the threat of colorectal most cancers in households with Lynch syndrome: a retrospective cohort examine. Lancet Oncol. 2021;22:1014–22.
Sarkeala T, Färkkilä M, Anttila A, Hyöty M, Kairaluoma M, Rautio T, et al. Piloting gender-oriented colorectal most cancers screening with a faecal immunochemical take a look at: population-based registry examine from Finland. BMJ Open. 2021;11:e046667.
Heinävaara S, Gini A, Sarkeala T, Anttila A, de Koning H, Lansdorp-Vogelaar I. Optimizing screening with faecal immunochemical take a look at for each sexes—cost-effectiveness evaluation from Finland. Preven Med. 2022;157:106990.
Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, et al. Screening for colorectal most cancers. J Am Med Assoc. 2021;325:1965.
Cardoso R, Guo F, Heisser T, Hackl M, Ihle P, De Schutter H, et al. Colorectal most cancers incidence, mortality, and stage distribution in European international locations within the colorectal most cancers screening period: a global population-based examine. Lancet Oncol. 2021;22:1002–13.
Dominguez-Valentin M, Sampson JR, Seppälä TT, Ten Broeke SW, Plazzer JP, Nakken S, et al. Most cancers dangers by gene, age, and gender in 6350 carriers of pathogenic mismatch restore variants: findings from the Potential Lynch Syndrome Database. Genet Med. 2020;22:15–25.
Lynch HT, De La Chapelle A. Hereditary colorectal most cancers. New Engl J Med. 2003;348:919–32.
Anaya DA, Chang GJ, Rodriguez-Bigas MA. Extracolonic manifestations of hereditary colorectal most cancers syndromes. Clin Colon Rectal Surg. 2008;21:263–72.
Archambault AN, Jeon J, Lin Y, Thomas M, Harrison TA, Bishop DT, et al. Threat stratification for early-onset colorectal most cancers utilizing a mixture of genetic and environmental threat scores: a global multi-center examine. JNCI: J Natl Most cancers Inst. 2022;114:528–39.
Mars N, Lindbohm JV, Della Briotta Parolo P, Widén E, Kaprio J, Palotie A, et al. Systematic comparability of household historical past and polygenic threat throughout 24 widespread illnesses. Am J Hum Genet. 2022;109:2152–62.
Burnett-Hartman AN, Lee JK, Demb J, Gupta S. An replace on the epidemiology, molecular characterization, analysis, and screening methods for early-onset colorectal most cancers. Gastroenterology. 2021;160:1041–9.
Møller P, Seppälä T, Dowty JG, Haupt S, Dominguez-Valentin M, Sunde L, et al. Colorectal most cancers incidences in Lynch syndrome: a comparability of outcomes from the potential Lynch syndrome database and the worldwide mismatch restore consortium. Hereditary Most cancers Clin Pract. 2022;20:36
Win AK, Dowty JG, Cleary SP, Kim H, Buchanan DD, Younger JP, et al. Threat of colorectal most cancers for carriers of mutations in MUTYH, with and and not using a household historical past of most cancers. Gastroenterology. 2014;146:1208–11.e1-5.
Gupta S, Lieberman D, Anderson JC, Burke CA, Dominitz JA, Kaltenbach T, et al. Suggestions for follow-up after colonoscopy and polypectomy: a consensus replace by the US multi-society activity drive on colorectal most cancers. Gastrointest Endosc. 2020;91:463–85.e5.
Lowery JT, Ahnen DJ, Schroy PC III, Hampel H, Baxter N, Boland CR, et al. Understanding the contribution of household historical past to colorectal most cancers threat and its medical implications: a state-of-the-science overview. Most cancers. 2016;122:2633–45.
Guo F, Edelmann D, Cardoso R, Chen X, Carr PR, Chang-Claude J, et al. Polygenic threat rating for outlining personalised surveillance intervals after adenoma detection and elimination at colonoscopy. Clin Gastroenterol Hepatol. 2023;21:210–9.e11.
Guo F, Weigl Ok, Carr PR, Heisser T, Jansen L, Knebel P, et al. Use of polygenic threat scores to pick screening intervals after adverse findings from colonoscopy. Clin Gastroenterol Hepatol. 2020;18:2742–51.e7.
Sullivan BA, Qin X, Redding TS IV, Gellad ZF, Stone A, Weiss D, et al. Genetic colorectal most cancers and adenoma threat variants are related to rising cumulative adenoma counts. Most cancers Epidemiol, Biomark Prev 2020;29:2269–76.
Carvajal–Carmona LG, Zauber AG, Jones AM, Howarth Ok, Wang J, Cheng T, et al. A lot of the genetic threat of colorectal most cancers is more likely to be mediated by means of susceptibility to adenomas. Gastroenterology. 2013;144:53–5.
Cheng THT, Gorman M, Martin L, Barclay E, Casey G, Saunders B, et al. Frequent colorectal most cancers threat alleles contribute to the a number of colorectal adenoma phenotype, however don’t affect colonic polyposis in FAP. Eur J Hum Genet. 2015;23:260–3.
Anderson JC, Butterly LF. Colonoscopy: high quality indicators. Clin Transl Gastroenterol. 2015;6:e77.
Mars N, Kerminen S, Feng Y-CA, Kanai M, Läll Ok, Thomas LF, et al. Genome-wide threat prediction of widespread illnesses throughout ancestries in a single million individuals. Cell Genomics. 2022;2:100118.
Lambert SA, Gil L, Jupp S, Ritchie SC, Xu Y, Buniello A, et al. The Polygenic Rating Catalog as an open database for reproducibility and systematic analysis. Nat Genet. 2021;53:420–5.
